中
|
EN
HOME
ABOUT US
Company profile
Memorabilia
Management team
Shareholder
Contact us
YB1 LEARNING ZONE
YB1 Papers
YB1 Headlines
YB1 Media
R&D AND PRODUCTS
Core technology
Products
Highlights
Patents
NEWS
Company news
Information
HOME
>
YB1 Papers
Bugs as Cancer Drugs Challenges and Opportunities Bugs作为癌症药物的挑战和机遇
论文出处： Beneficial Microbes
发表时间：2020.1.8
Source： Beneficial Microbes
Published： 8 January 2020
【View PDF】
Last：
IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered SalmonellaIFN-γ依赖性NK细胞的激活对工程沙门氏菌抑制转移至关重要?
Next：
Bifidobacterium breve as a delivery vector of IL-24 gene 短双歧杆菌作为IL-24基因的传递载体
